Alamar Biosciences, Inc.

NASDAQ:ALMR

Biotechnology

Healthcare
$30.51 +5.50%

+$1.11 today

Market cap
$2.12B
Beta
0.00
P/E (TTM)
-47.5
EPS (TTM)
-$0.45
52W Low $18.85High $27.20

Volume 0.53M

Average 0.38M

ALMR Other Non-Cash Items

Other non-cash adjustments that reconcile net income to operating cash flow.

Alamar Biosciences, Inc.NASDAQ: ALMR

Other Non-Cash Items · Q2 FY2026 · quarter ended Jun 2026

Other non-cash items of $5.52M in Q2 FY2026

Q2 FY2026 other non-cash items was $5.52M.

Context

  • Other non-cash items amounted to 2.8% of revenue in FY2025.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterJun 2026
$5.52M-50.7% QoQ
Last fiscal yearDec 2025
$2.05M— YoY
Other Non-Cash Items past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Other Non-Cash Items history

USD · from the cash flow

Latest · FY2025
2.05M USD
Year-over-year change
—

Other Non-Cash Items vs competitors

How ALMR compares with its peers on the latest reported figures

  • ALMR's FY2025 other non-cash items of $2.05M is the 7th largest of the 9 companies compared; the peer median is $189K.
  • Other non-cash items amounts to 2.8% of revenue for ALMR, versus a peer median of 12.8%.
ALMR Competitors Peer median
Other Non-Cash Items for ALMR and competitors
Company Period LTM YoY 3-year CAGR% of revenue
LABStandard BioTools Inc.LTM Mar 2026$120.26M +6460.7%-44.5%139.4%
TECHBio-Techne CorporationLTM Sep 2026$51.93M -151.1%-80.8%4.2%
PACBPacific Biosciences of California, Inc.LTM Mar 2026$20.55M -176.5%-29.4%12.8%
SEERSeer, Inc.LTM Mar 2026$8.38M +15.1%+62.1%55.7%
TWSTTwist Bioscience CorporationLTM Sep 2026$7.99M +117.1%-59.5%1.7%
TXG10x Genomics, Inc.LTM Jun 2026$7.4M +3875.0%-4.2%1.2%
ALMRAlamar Biosciences, Inc.FY2025$2.05M ——2.8%
NAUTNautilus Biotechnology, Inc.LTM Mar 2026$947K -45.9%+16.9%—
QSIQuantum-Si incorporatedLTM Mar 2026$569K +107.2%—30.7%
Peer median (excluding ALMR) $189K+61.2%-29.4%12.8%

Competitors are the stored peer set for ALMR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Alamar Biosciences, Inc.

NASDAQ:ALMR

Intrinsic Alpha fair value

Locked

Current Price

$30.51

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.